Immunome, Inc.

7.73 USD
+0.03 (+0.39%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Immunome, Inc. stock is down -9.7% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 December’s closed higher than November.

About Immunome, Inc.

Immunome, Inc. discovers and develops antibody therapeutics for oncology and infectious disease. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.